(NYSE: ALB) Albemarle's forecast annual revenue growth rate of 8.03% is forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 4.77%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.47%.
Albemarle's revenue in 2026 is $5,142,733,000.On average, 27 Wall Street analysts forecast ALB's revenue for 2026 to be $668,782,973,500, with the lowest ALB revenue forecast at $542,215,059,220, and the highest ALB revenue forecast at $864,762,900,360. On average, 25 Wall Street analysts forecast ALB's revenue for 2027 to be $710,147,347,720, with the lowest ALB revenue forecast at $587,468,391,700, and the highest ALB revenue forecast at $951,851,995,940.
In 2028, ALB is forecast to generate $768,363,874,400 in revenue, with the lowest revenue forecast at $603,613,460,840 and the highest revenue forecast at $983,906,439,780.